Investigating the genetic and brain structure factors behind neuropsychiatric symptoms in Alzheimer's disease across diverse populations.
Genetic and neuroanatomical basis of neuropsychiatric symptoms in Alzheimer's disease in populations of diverse ancestry
This study is looking at how genes and brain structure might affect feelings like aggression and anxiety in people with Alzheimer's, especially focusing on those from different backgrounds, to help find better ways to support and treat them.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10889915 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic and neuroanatomical factors that contribute to neuropsychiatric symptoms, such as aggression and anxiety, in patients with Alzheimer's disease. By studying a diverse group of individuals, including those from underserved racial and ethnic backgrounds, the research aims to fill the knowledge gap regarding these symptoms and their impact on patient care. The approach involves analyzing genetic data and brain imaging from a large cohort of approximately 60,000 individuals to identify patterns and potential treatment targets. This could lead to more effective interventions tailored to the needs of diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, particularly those exhibiting neuropsychiatric symptoms and belonging to diverse racial and ethnic backgrounds.
Not a fit: Patients without a diagnosis of Alzheimer's disease or those not exhibiting neuropsychiatric symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for neuropsychiatric symptoms in Alzheimer's patients, enhancing their quality of life.
How similar studies have performed: Previous research initiatives focusing on diverse populations in Alzheimer's disease have shown promise, indicating that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Reitz, Christiane — Columbia University Health Sciences
- Study coordinator: Reitz, Christiane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.